Avammune Therapeutics is a small molecule drug discovery and development company integrating novel target biology, immunology, computational chemistry, and high-throughput chemistry to build a cost-efficient, flexible model that leads to the identification of novel targets and a proprietary pipeline of small-molecule drug candidates for potential use in oncology.